Borenius > References > M&A & Private Equity > Borenius advised SYNLAB in the acquisition of Cityterveys
M&A & Private Equity / 7 Jul 2017

Borenius advised SYNLAB in the acquisition of Cityterveys

We advised SYNLAB in the acquisition of all shares in Cityterveys, a leading Finnish private healthcare company specialising in diagnostic services.

With over 17,000 employees, the SYNLAB Group is the leading medical diagnostics provider in Europe. SYNLAB operates in more than 30 countries and carries out 450 million laboratory tests per year, achieving sales revenues of approximately EUR 1.6 billion.

Cityterveys has experience in the field of diagnostic services, including imaging and laboratory services. Services are offered to private healthcare service providers, national and regional public institutions, and private individuals. Cityterveys operates a network of 26 locations, and its headquarters are in Helsinki, Finland.

By concluding this transaction, SYNLAB has become one of the most significant players on the market segment for private diagnostic service providers in Finland.

Share on LinkedInTweet about this on TwitterShare on Facebook